274 related articles for article (PubMed ID: 17206525)
1. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
Levi M; Dempsey DA; Benowitz NL; Sheiner LB
J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):23-34. PubMed ID: 17206525
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of nicotine and its metabolites I. Model development.
Levi M; Dempsey DA; Benowitz NL; Sheiner LB
J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):5-21. PubMed ID: 17206524
[TBL] [Abstract][Full Text] [Related]
3. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity.
Dempsey D; Tutka P; Jacob P; Allen F; Schoedel K; Tyndale RF; Benowitz NL
Clin Pharmacol Ther; 2004 Jul; 76(1):64-72. PubMed ID: 15229465
[TBL] [Abstract][Full Text] [Related]
4. Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate.
Lea RA; Dickson S; Benowitz NL
J Anal Toxicol; 2006; 30(6):386-9. PubMed ID: 16872570
[TBL] [Abstract][Full Text] [Related]
5. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
PLoS One; 2013; 8(8):e70938. PubMed ID: 23936477
[TBL] [Abstract][Full Text] [Related]
6. Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers.
Ho MK; Mwenifumbo JC; Al Koudsi N; Okuyemi KS; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2009 Jun; 85(6):635-43. PubMed ID: 19279561
[TBL] [Abstract][Full Text] [Related]
7. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
[TBL] [Abstract][Full Text] [Related]
8. Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urine.
Swan GE; Lessov-Schlaggar CN; Bergen AW; He Y; Tyndale RF; Benowitz NL
Pharmacogenet Genomics; 2009 May; 19(5):388-98. PubMed ID: 19300303
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
Williams JM; Gandhi KK; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2582-9. PubMed ID: 20719908
[TBL] [Abstract][Full Text] [Related]
10. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.
Mwenifumbo JC; Lessov-Schlaggar CN; Zhou Q; Krasnow RE; Swan GE; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2008 Jan; 83(1):115-21. PubMed ID: 17522595
[TBL] [Abstract][Full Text] [Related]
12. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
Hukkanen J; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
[TBL] [Abstract][Full Text] [Related]
13. Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans.
Nakajima M; Yamagishi S; Yamamoto H; Yamamoto T; Kuroiwa Y; Yokoi T
Clin Pharmacol Ther; 2000 Jan; 67(1):57-69. PubMed ID: 10668854
[TBL] [Abstract][Full Text] [Related]
14. The Associations of
Mahabee-Gittens EM; Matt GE; Jandarov RA; Merianos AL
Int J Environ Res Public Health; 2023 Apr; 20(9):. PubMed ID: 37174159
[TBL] [Abstract][Full Text] [Related]
15. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
Benowitz NL; Zevin S; Jacob P
Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
[TBL] [Abstract][Full Text] [Related]
16. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.
Jacob P; Yu L; Duan M; Ramos L; Yturralde O; Benowitz NL
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(3-4):267-76. PubMed ID: 21208832
[TBL] [Abstract][Full Text] [Related]
17. Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.
Tanner JA; Novalen M; Jatlow P; Huestis MA; Murphy SE; Kaprio J; Kankaanpää A; Galanti L; Stefan C; George TP; Benowitz NL; Lerman C; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1239-46. PubMed ID: 26014804
[TBL] [Abstract][Full Text] [Related]
18. Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.
Fogli S; Saba A; Del Re M; Pistelli F; Aquilini F; Zucchi R; Palla A; Breschi MC; Carrozzi L; Danesi R
J Pharm Biomed Anal; 2016 Nov; 131():208-213. PubMed ID: 27599351
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy-Induced Increases in the Nicotine Metabolite Ratio: Examining Changes During Antepartum and Postpartum.
Arger CA; Taghavi T; Heil SH; Skelly J; Tyndale RF; Higgins ST
Nicotine Tob Res; 2019 Nov; 21(12):1706-1710. PubMed ID: 30165458
[TBL] [Abstract][Full Text] [Related]
20. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers.
Berlin I; Gasior MJ; Moolchan ET
Nicotine Tob Res; 2007 Apr; 9(4):493-8. PubMed ID: 17454704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
